{"schema_version":"1","generated_at":"2026-11-20T23:34:00.423Z","data_as_of":null,"url":"https://www.findmykol.com/kol/janet-fairley","json_url":"https://www.findmykol.com/kol/janet-fairley/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"janet-fairley","name":"Janet Fairley","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"University of Iowa","institution_url":"https://www.findmykol.com/institution/university-of-iowa","city":"Iowa City","state":"IA","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Janet Fairley is a Dermatology physician affiliated with University of Iowa. OpenAlex indexes 166 publications with 8,788 citations (h-index 48); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":166,"cited_by_count":8788,"h_index":48,"latest_activity_year":2025,"citation_standing":{"top_percent":5,"cohort":"Dermatology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00472030","title":"Efficacy and Safety of Omalizumab in Bullous Pemphigoid","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"University of Iowa","source_url":"https://clinicaltrials.gov/study/NCT00472030","trial_url":"https://www.findmykol.com/trial/NCT00472030"},{"nct":"NCT00283712","title":"Use of Infliximab for the Treatment of Pemphigus Vulgaris","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","source_url":"https://clinicaltrials.gov/study/NCT00283712","trial_url":"https://www.findmykol.com/trial/NCT00283712"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"Regeneron","program_year":2025,"amount_usd":12170.15,"payment_count":6},{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2025,"amount_usd":30.46,"payment_count":1},{"payer":"AstraZeneca","program_year":2024,"amount_usd":8398,"payment_count":1}],"source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2011,"last":2021},"rows_total":6,"shown":3,"withheld":3,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21AG065980","title":"Modulation of Cutaneous Autoimmunity by Staphylococcus Aureus","fiscal_year":2021,"amount_usd":"198720","organization":"UNIVERSITY OF IOWA","source_url":"https://reporter.nih.gov/quickSearch/R21AG065980"},{"project":"R21AG065980","title":"Modulation of Cutaneous Autoimmunity by Staphylococcus Aureus","fiscal_year":2020,"amount_usd":"240070","organization":"UNIVERSITY OF IOWA","source_url":"https://reporter.nih.gov/quickSearch/R21AG065980"},{"project":"I01CX000317","title":"The Role of IgE in Autoimmune Skin Diseases","fiscal_year":2013,"organization":"IOWA CITY VA MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/I01CX000317"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic","year":2020,"journal":"Journal of the European Academy of Dermatology and Venereology","source_url":"https://doi.org/10.1111/jdv.16525","status":"verified"},{"title":"The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid","year":2019,"journal":"Frontiers in Immunology","source_url":"https://doi.org/10.3389/fimmu.2019.02331","status":"verified"},{"title":"International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita","year":2017,"journal":"British Journal of Dermatology","source_url":"https://doi.org/10.1111/bjd.16138","status":"verified"},{"title":"Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid","year":2017,"journal":"Journal of Investigative Dermatology","source_url":"https://doi.org/10.1016/j.jid.2017.11.031","status":"verified"},{"title":"Age-dependent variation in cytokines, chemokines and biologic analytes rinsed from the surface of healthy human skin","year":2015,"journal":"Scientific Reports","source_url":"https://doi.org/10.1038/srep10472","status":"verified"}],"source":"works"},"similar":[{"name":"Lawrence Hunsicker","slug":"lawrence-hunsicker","institution":"University of Iowa","specialty":"Nephrology","url":"https://www.findmykol.com/kol/lawrence-hunsicker","json_url":"https://www.findmykol.com/kol/lawrence-hunsicker/profile.json"},{"name":"Brian Olshansky","slug":"brian-olshansky","institution":"University of Iowa","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/brian-olshansky","json_url":"https://www.findmykol.com/kol/brian-olshansky/profile.json"},{"name":"Robert Weiss","slug":"robert-weiss","institution":"University of Iowa","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/robert-weiss","json_url":"https://www.findmykol.com/kol/robert-weiss/profile.json"},{"name":"Carla Nester","slug":"carla-nester","institution":"University of Iowa","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/carla-nester","json_url":"https://www.findmykol.com/kol/carla-nester/profile.json"},{"name":"Bridget Grant","slug":"bridget-grant","institution":"Bassett Medical Center","specialty":"Dermatology","url":"https://www.findmykol.com/kol/bridget-grant","json_url":"https://www.findmykol.com/kol/bridget-grant/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Andrew Blauvelt","slug":"andrew-blauvelt","institution":"University of Maryland School of Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/andrew-blauvelt","json_url":"https://www.findmykol.com/kol/andrew-blauvelt/profile.json"},{"name":"Howard Maibach","slug":"howard-maibach","institution":"University of California, San Francisco","specialty":"Dermatology","url":"https://www.findmykol.com/kol/howard-maibach","json_url":"https://www.findmykol.com/kol/howard-maibach/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":5,"funding":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}